Erenumab
Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine[1].
Product Specifications
CAS Number
1582205-90-0
Product Name Alternative
AMG-334
UNSPSC
12352203
Target
CGRP Receptor
Type
Inhibitory Antibodies
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/erenumab.html
Purity
98.88
Solubility
H2O
Smiles
[Erenumab]
Molecular Weight
(145.5 kDa)
References & Citations
[1]Goadsby PJ, Reuter U, Hallström Y, et al. A Controlled Trial of Erenumab for Episodic Migraine. N Engl J Med. 2017;377 (22) :2123-2132.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
041660-ML650 100 µL
Sgk223, NT (Sgk223, D8Ertd82e, Tyrosine-protein kinase SgK223, Sugen kinase 223) (MaxLight 650) discontinued
Sign In for Pricing
View Details ![Rabbit Polyclonal RAB39B Antibody [DyLight 550]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
MBS1346651 Inquire
Recombinant Dictyostelium discoideum DNA-directed RNA polymerase I subunit rpa1 (polr1a), partial
Sign In for Pricing
View Details